InSphero Hires New Director of Global Marketing
News Jan 30, 2014
With Dr. Strube, InSphero won a technically skilled and very experienced life science professional to continue its remarkable growth over the past years. Previously, Dr. Strube has helped build outstanding marketing frameworks for successful companies such as Enzo Life Sciences, Inc. and Assay Designs, Inc. As a trained microbiologist with a Ph.D. in cancer biology, he also brings the necessary technical background to help InSphero educate and inform the life science community about the advantages of 3D-cell-based assays over conventional 2D monolayers.
"As a rapidly growing, global innovation driver in the field of 3D cell-culture, we have a lot to tell" explains Dr. Jan Lichtenberg, CEO and co-founder of InSphero. "With Dr. Strube joining us, we will be faster and more to the point in explaining InSphero's cutting-edge products and services to drug-discovery and drug-safety customers all over the world."
Excited to be part of the InSphero team, Dr. Strube commented, "The scientific and executive leadership at InSphero have established a technology, in-house expertise, and strategic partnerships that clearly distinguish InSphero within the 3D marketplace. I'm honored for the opportunity to help build the InSphero brand globally and to communicate the industry-transforming benefits of our technology to the scientific community."
More than half of the drugs that have entered the market in Germany since then have emerged from these assessments without any proven added benefit. In a new publication using the first 216 assessments, researchers examine the reasons for this sobering result and develop suggestions for improvements in drug development.READ MORE